Trial Profile
V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2017
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Psychotic disorders
- Focus Therapeutic Use
- Acronyms V3
- 11 Apr 2011 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Sep 2010 Additional lead trial centre and trial investigator (Honer W) identified as reported by ClinicalTrials.gov.